ALB-001

N/A

Report date: 2025/01/26 18:09:48

NME

Base Information

Drug NameALB-001

Drug Alias Nameinhibitors of shared epitope-calreticulin interactions (University of Michigan)calreticulin inhibitors (Alibion/University of Michigan)ALB-001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCalreticulin inhibitors

TargetsCalreticulin

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Michigan

China Registration ClassN/A

Develop Information

Active CompaniesAlibion AG

Inactive CompaniesUniversity Of Michigan

Active IndicationsArthritis, Rheumatoid

Inactive IndicationsN/A

Other Information

ATC CodeN/A